A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
Zhuoyuan Zhong,1,* Limin Wang,2,* Xiaojun Wen,3 Yunyun Liu,4 Yafei Fan,5 Zhonglin Liu5 1Department of Neurology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China; 2Department of Neurology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdon...
Enregistré dans:
Auteurs principaux: | Zhong Z, Wang L, Wen X, Liu Y, Fan Y, Liu Z |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6e0b09f384aa44099bba627583de7b41 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
par: Xin KZ, et autres
Publié: (2019) -
Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
par: Najmeh Shahini, et autres
Publié: (2021) -
A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
par: Cui YH, et autres
Publié: (2016) -
Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
par: Kurita M
Publié: (2016) -
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
par: McIntyre RS
Publié: (2017)